Your browser doesn't support javascript.
loading
Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours.
Hunter, Sally M; Dall, Genevieve V; Doyle, Maria A; Lupat, Richard; Li, Jason; Allan, Prue; Rowley, Simone M; Bowtell, David; Campbell, Ian G; Gorringe, Kylie L.
Afiliación
  • Hunter SM; Cancer Genomics Program, Peter MacCallum Cancer Centre, East Melbourne, Australia.
  • Dall GV; Cancer Genomics Program, Peter MacCallum Cancer Centre, East Melbourne, Australia.
  • Doyle MA; Bioinformatics Core Facility Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
  • Lupat R; Bioinformatics Core Facility Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
  • Li J; Bioinformatics Core Facility Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
  • Allan P; Anatomical Pathology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
  • Rowley SM; Cancer Genomics Program, Peter MacCallum Cancer Centre, East Melbourne, Australia.
  • Bowtell D; Cancer Genomics Program, Peter MacCallum Cancer Centre, East Melbourne, Australia.
  • Campbell IG; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
BMC Res Notes ; 13(1): 349, 2020 Jul 22.
Article en En | MEDLINE | ID: mdl-32698852
ABSTRACT

OBJECTIVE:

Ovarian fibromas and adenofibromas are rare ovarian tumours. They are benign tumours composed of spindle-like stromal cells (pure fibroma) or a mixture of fibroblast and epithelial components (adenofibroma). We have previously shown that 40% of benign serous ovarian tumours are likely primary fibromas due to the neoplastic alterations being restricted to the stromal compartment of these tumours. We further explore this finding by comparing benign serous tumours to pure fibromas.

RESULTS:

Performing copy number aberration (CNA) analysis on the stromal component of 45 benign serous tumours and 8 pure fibromas, we have again shown that trisomy of chromosome 12 is the most common aberration in ovarian fibromas. CNAs were more frequent in the pure fibromas than the benign serous tumours (88% vs 33%), however pure fibromas more frequently harboured more than one CNA event compared with benign serous tumours. As these extra CNA events observed in the pure fibromas were unique to this subset our data indicates a unique tumour evolution. Gene expression analysis on the two cohorts was unable to show gene expression changes that differed based on tumour subtype. Exome analysis did not reveal any recurrently mutated genes.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Fibroma Idioma: En Revista: BMC Res Notes Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Fibroma Idioma: En Revista: BMC Res Notes Año: 2020 Tipo del documento: Article